Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pearson

Showing results (1181-1190 of 1,239) with videos related to

Pageof 124
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumorsSean Carlin, Rob J Mairs, Anthony G McCluskey, et al.
Cancer Research|March 17, 2019
MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic TreatmentKonstantinos Zormpas-Petridis, Neil P Jerome, Matthew D Blackledge, et al.
Journal of Neuro-Oncology|May 16, 2016
Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine gliomaFernando Carceller, Lucy A Fowkes, Komel Khabra, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2016
Implementation of mechanism of action biology-driven early drug development for children with cancerAndrew D J Pearson, Ralf Herold, Raphaël Rousseau, et al.
Cell Reports|February 15, 2018
Glucagon Receptor Antagonism Improves Glucose Metabolism and Cardiac Function by Promoting AMP-Mediated Protein Kinase in Diabetic MiceAnkit X Sharma, Ezekiel B Quittner-Strom, Young Lee, et al.
Elife|March 23, 2023
Lipid hydroperoxides promote sarcopenia through carbonyl stressHiroaki Eshima, Justin L Shahtout, Piyarat Siripoksup, et al.
The Canadian Journal of Cardiology|October 8, 2016
2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the AdultTodd J Anderson, Jean Grégoire, Glen J Pearson, et al.
The Canadian Journal of Cardiology|October 9, 2009
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendationsJacques Genest, Ruth McPherson, Jiri Frohlich, et al.
Cancers|February 5, 2020
Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)Ruth Ladenstein, Ulrike Pötschger, Dominique Valteau-Couanet, et al.
The Lancet. Oncology|November 17, 2018
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trialRuth Ladenstein, Ulrike Pötschger, Dominique Valteau-Couanet, et al.
Pageof 124

Showing results (1181-1190 of 1,239) with videos related to

Sort By:
Pageof 124
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumorsSean Carlin, Rob J Mairs, Anthony G McCluskey, et al.
Cancer Research|March 17, 2019
MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic TreatmentKonstantinos Zormpas-Petridis, Neil P Jerome, Matthew D Blackledge, et al.
Journal of Neuro-Oncology|May 16, 2016
Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine gliomaFernando Carceller, Lucy A Fowkes, Komel Khabra, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2016
Implementation of mechanism of action biology-driven early drug development for children with cancerAndrew D J Pearson, Ralf Herold, Raphaël Rousseau, et al.
Cell Reports|February 15, 2018
Glucagon Receptor Antagonism Improves Glucose Metabolism and Cardiac Function by Promoting AMP-Mediated Protein Kinase in Diabetic MiceAnkit X Sharma, Ezekiel B Quittner-Strom, Young Lee, et al.
Elife|March 23, 2023
Lipid hydroperoxides promote sarcopenia through carbonyl stressHiroaki Eshima, Justin L Shahtout, Piyarat Siripoksup, et al.
The Canadian Journal of Cardiology|October 8, 2016
2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the AdultTodd J Anderson, Jean Grégoire, Glen J Pearson, et al.
The Canadian Journal of Cardiology|October 9, 2009
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendationsJacques Genest, Ruth McPherson, Jiri Frohlich, et al.
Cancers|February 5, 2020
Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)Ruth Ladenstein, Ulrike Pötschger, Dominique Valteau-Couanet, et al.
The Lancet. Oncology|November 17, 2018
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trialRuth Ladenstein, Ulrike Pötschger, Dominique Valteau-Couanet, et al.
Pageof 124